157 related articles for article (PubMed ID: 36951682)
1. G-CSF Is a Novel Mediator of T-Cell Suppression and an Immunotherapeutic Target for Women with Colon Cancer.
Ray AL; Saunders AS; Nofchissey RA; Reidy MA; Kamal M; Lerner MR; Fung KM; Lang ML; Hanson JA; Guo S; Urdaneta-Perez MG; Lewis SE; Cloyde M; Morris KT
Clin Cancer Res; 2023 Jun; 29(11):2158-2169. PubMed ID: 36951682
[TBL] [Abstract][Full Text] [Related]
2. G-CSF and G-CSFR Modulate CD4 and CD8 T Cell Responses to Promote Colon Tumor Growth and Are Potential Therapeutic Targets.
Karagiannidis I; Jerman SJ; Jacenik D; Phinney BB; Yao R; Prossnitz ER; Beswick EJ
Front Immunol; 2020; 11():1885. PubMed ID: 33042110
[TBL] [Abstract][Full Text] [Related]
3. Highly Expressed Granulocyte Colony-Stimulating Factor (G-CSF) and Granulocyte Colony-Stimulating Factor Receptor (G-CSFR) in Human Gastric Cancer Leads to Poor Survival.
Fan Z; Li Y; Zhao Q; Fan L; Tan B; Zuo J; Hua K; Ji Q
Med Sci Monit; 2018 Mar; 24():1701-1711. PubMed ID: 29567938
[TBL] [Abstract][Full Text] [Related]
4. [Expression of granulocyte colony-stimulating factor receptor in colitis-associated colonic carcinogenesis].
Wang W; Yuan W; Wei XD; Qi J; Ma J
Zhonghua Zhong Liu Za Zhi; 2018 Sep; 40(9):653-658. PubMed ID: 30293388
[No Abstract] [Full Text] [Related]
5. Granulocyte colony-stimulating factor/granulocyte colony-stimulating factor receptor biological axis promotes survival and growth of bladder cancer cells.
Chakraborty A; Guha S
Urology; 2007 Jun; 69(6):1210-5. PubMed ID: 17572226
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte colony-stimulating factor receptor signals for beta1-integrin expression and adhesion in bladder cancer.
Chakraborty A; White SM; Lerner SP
Urology; 2004 Jan; 63(1):177-83. PubMed ID: 14751388
[TBL] [Abstract][Full Text] [Related]
7. G-CSF and GM-CSF concentrations and receptor expression in peripheral blood leukemic cells from patients with chronic myelogenous leukemia.
Lee J; Kim Y; Lim J; Kim M; Han K
Ann Clin Lab Sci; 2008; 38(4):331-7. PubMed ID: 18988925
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte colony-stimulating receptor promotes beta1-integrin-mediated adhesion and invasion of bladder cancer cells.
Chakraborty A; White SM; Guha S
Urology; 2006 Jul; 68(1):208-13. PubMed ID: 16844458
[TBL] [Abstract][Full Text] [Related]
9. G-CSF and G-CSFR are highly expressed in human gastric and colon cancers and promote carcinoma cell proliferation and migration.
Morris KT; Khan H; Ahmad A; Weston LL; Nofchissey RA; Pinchuk IV; Beswick EJ
Br J Cancer; 2014 Mar; 110(5):1211-20. PubMed ID: 24448357
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of granulocyte colony-stimulating factor-mediated myeloid maturation by low level expression of the differentiation-defective class IV granulocyte colony-stimulating factor receptor isoform.
White SM; Alarcon MH; Tweardy DJ
Blood; 2000 Jun; 95(11):3335-40. PubMed ID: 10828013
[TBL] [Abstract][Full Text] [Related]
11. Expression of granulocyte-colony-stimulating factor and its receptor in human Ewing sarcoma cells and patient tumor specimens: potential consequences of granulocyte-colony-stimulating factor administration.
Morales-Arias J; Meyers PA; Bolontrade MF; Rodriguez N; Zhou Z; Reddy K; Chou AJ; Koshkina NV; Kleinerman ES
Cancer; 2007 Oct; 110(7):1568-77. PubMed ID: 17694551
[TBL] [Abstract][Full Text] [Related]
12. Proteolytic cleavage of granulocyte colony-stimulating factor and its receptor by neutrophil elastase induces growth inhibition and decreased cell surface expression of the granulocyte colony-stimulating factor receptor.
Hunter MG; Druhan LJ; Massullo PR; Avalos BR
Am J Hematol; 2003 Nov; 74(3):149-55. PubMed ID: 14587040
[TBL] [Abstract][Full Text] [Related]
13. Specific signals generated by the cytoplasmic domain of the granulocyte colony-stimulating factor (G-CSF) receptor are not required for G-CSF-dependent granulocytic differentiation.
Jacob J; Haug JS; Raptis S; Link DC
Blood; 1998 Jul; 92(2):353-61. PubMed ID: 9657731
[TBL] [Abstract][Full Text] [Related]
14. Characterization of granulocyte colony-stimulating factor receptor expressed on human lymphocytes.
Morikawa K; Morikawa S; Nakamura M; Miyawaki T
Br J Haematol; 2002 Jul; 118(1):296-304. PubMed ID: 12100165
[TBL] [Abstract][Full Text] [Related]
15. Granulocyte colony-stimulating factor (G-CSF)-mediated signaling regulates type IV collagenase activity in head and neck cancer cells.
Sugimoto C; Fujieda S; Sunaga H; Noda I; Tanaka N; Kimura Y; Saito H; Matsukawa S
Int J Cancer; 2001 Jul; 93(1):42-6. PubMed ID: 11391619
[TBL] [Abstract][Full Text] [Related]
16. Targeting inhibition of prognosis-related lipid metabolism genes including CYP19A1 enhances immunotherapeutic response in colon cancer.
Liu L; Mo M; Chen X; Chao D; Zhang Y; Chen X; Wang Y; Zhang N; He N; Yuan X; Chen H; Yang J
J Exp Clin Cancer Res; 2023 Apr; 42(1):85. PubMed ID: 37055842
[TBL] [Abstract][Full Text] [Related]
17. Transfer of recombinant human granulocyte colony stimulating factor (rhG-CSF) from the maternal to the fetal circulation is not dependent upon a functional G-CSF-receptor.
Calhoun DA; Gersting JA; Lunøe M; Du Y; Christensen RD
Placenta; 2001 Jul; 22(6):609-12. PubMed ID: 11440552
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy.
Li B; Lalani AS; Harding TC; Luan B; Koprivnikar K; Huan Tu G; Prell R; VanRoey MJ; Simmons AD; Jooss K
Clin Cancer Res; 2006 Nov; 12(22):6808-16. PubMed ID: 17121902
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte colony-stimulating factor decreases the Th1/Th2 ratio in peripheral blood mononuclear cells from patients with chronic immune thrombocytopenic purpura in vitro.
Ge F; Zhang Z; Hou J; Cao F; Zhang Y; Wang P; Wei H; Zhou J
Thromb Res; 2016 Dec; 148():76-84. PubMed ID: 27815970
[TBL] [Abstract][Full Text] [Related]
20. G-CSF and G-CSFR Induce a Pro-Tumorigenic Macrophage Phenotype to Promote Colon and Pancreas Tumor Growth.
Karagiannidis I; de Santana Van Vilet E; Said Abu Egal E; Phinney B; Jacenik D; Prossnitz ER; Beswick EJ
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33036138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
